Seeking Alpha

GENT
Gentium SpA

5/27/2012, 4:27 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
GENT Market Currents more »
  • December 29, 2011 Gentium (GENT -4.3%) trades lower today after saying it expects to submit answers for its lead product candidate Defibrotide to European regulators during Q1 of 2012. The drug is used to treat and prevent hepatic veno-occlusive disease in adults and children undergoing haematopoietic stem-cell transplantation therapy.
    Comment!
    [Healthcare, Global & FX, On the Move]
GENT in Focus more »
GENT Latest Transcript more »
Currently, there are no transcripts for GENT.
GENT Cramer more »
Currently, there are no Cramer articles on GENT.
GENT Instablog posts more »
  • Gentium (GENT) Posts Q2, HY 2011 Financial Results
    Wed, Sep 21, 2011 • MissionIR • Comment!
  • Gentium (GENT) Posts Q2, HY 2011 Financial Results
    Wed, Sep 21, 2011 • QualityStocks • Comment!
  • (PETM, CRWE, CLNO, SRSL, GENT, CENT) Notable Stock by Stock-PR
    Sat, Jun 18, 2011 • stock-PR.com • Comment!
  • Gentium S.p.A (GENT) Appoints Adrian Haigh as Senior Vice President, Commercial Operations
    Thu, Mar 3, 2011 • QualityStocks • Comment!
  • GENT growing 10/7/10-
    Thu, Oct 7, 2010 • jrusso9722 • Comment!
Write a post on GENT
GENT StockTalks
GENT vs. ETF Alternatives
Company Description
Currently, there's no company description for GENT.
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: Italy